You are invited to learn about the future of clinical outcomes assessments in GN, patient-focused drug development, and the PrepareNS study (FDA-funded to develop a validated clinical outcomes assessment instrument in nephrotic syndrome that can be used in future clinical trials). There will also be a patient panel with patients discussing their experiences with edema and related symptoms.
Further information and the registration can be found here